Literature DB >> 32283240

Back to the basics: Diluted bleach for COVID-19.

Parth Patel1, Sanjna Sanghvi2, Kunal Malik3, Amor Khachemoune4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32283240      PMCID: PMC7151288          DOI: 10.1016/j.jaad.2020.04.033

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
To the Editor: Since December 2019, COVID-19. a highly pathogenic novel human coronavirus severe acute respiratory syndrome coronavirus (SARS-Cov-2), has emerged from China harboring high human-to-human transmission rates and persistence on inanimate surfaces. An analysis of 22 studies revealed that human coronaviruses similar to COVID-19, including SARS coronavirus, Middle East respiratory syndrome (MERS) coronavirus, and endemic human coronaviruses (HCoV), can persist on inanimate surfaces, such as metal, glass, or plastic, for up to 9 days, but are efficiently inactivated by 62% to 71% ethanol, 0.5% hydrogen peroxide, or 0.1% sodium hypochlorite within 1 minute. A study by van Doremalen et al evaluating the stability of COVID-19 and SARS-CoV-1 suggests that COVID-19 may remain viable for hours to days on surfaces made from a variety of materials. To help identify commercial disinfectants against COVID-19, the United States Environmental Protection Agency (EPA) has created a list of adequate products by their EPA registration number. Unfortunately, with exponentially rising COVID-19 cases in the United States, commercial disinfect supplies are in high demand and will unquestionably be limited in the near future. We will have to get creative with available resources, all the while taking safe precautions to ensure our efforts improve and not worsen the ongoing situation. Various dilutions of sodium hypochlorite, effectively Dakin's solution, have been tried and true in dermatology and wound care for many years. To achieve the formulation noted by Kampf et al, ∼0.1% sodium hypochlorite can be made by a roughly 1:50 dilution of household bleach (∼5.25% to 6% sodium hypochlorite) in tap water. Although the Kampf et al analysis is a combination of non–COVID-19 studies, we expect the proposed formulation to similarly also disinfect surfaces of the novel coronavirus. The Centers for Disease Control and Prevention (CDC) also recommends an approximately 1:50 dilution to disinfect COVID-19, explicitly noting 5 tablespoons (one-third cup) bleach per gallon of water or 4 teaspoons bleach per quart of water. Different dilutions of sodium hypochlorite can vary in their in vivo fibroblast and keratinocyte cytotoxicity; however, dilutions of ∼0.1% sodium hypochlorite are clinically effective with minimal irritation or sensitization. One should be mindful that corrosive injury on mucous membrane/skin contact is possible with excess volumes or mishandling, so appropriate caution and moderation is necessary. This solution should ideally be used within 1 month of preparation and stored in a closed, opaque container at room temperature. While the exact viral load on inanimate surfaces is unknown during an outbreak, it is critical to disinfect frequently touched surfaces. With rapidly diminishing availability of commercial cleaning supplies, simple diluted bleach, which is readily available, can effectively disinfect our clinics, homes, and environment to prevent sustained transmission from inanimate objects. As with many disinfectants, minimizing long-term skin contact and ensuring good ventilation can minimize clinical toxicity. In Henry Dakin's spirit, we should strive to share with our colleagues the cost-effective, accessible, and relatively safe power of diluted bleach.
  3 in total

Review 1.  The clinical toxicology of sodium hypochlorite.

Authors:  Robin J Slaughter; Martin Watts; J Allister Vale; Jacob R Grieve; Leo J Schep
Journal:  Clin Toxicol (Phila)       Date:  2019-01-28       Impact factor: 4.467

Review 2.  Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.

Authors:  G Kampf; D Todt; S Pfaender; E Steinmann
Journal:  J Hosp Infect       Date:  2020-02-06       Impact factor: 3.926

3.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

Authors:  Neeltje van Doremalen; Trenton Bushmaker; Dylan H Morris; Myndi G Holbrook; Amandine Gamble; Brandi N Williamson; Azaibi Tamin; Jennifer L Harcourt; Natalie J Thornburg; Susan I Gerber; James O Lloyd-Smith; Emmie de Wit; Vincent J Munster
Journal:  N Engl J Med       Date:  2020-03-17       Impact factor: 91.245

  3 in total
  1 in total

1.  Fully digital pathology laboratory routine and remote reporting of oral and maxillofacial diagnosis during the COVID-19 pandemic: a validation study.

Authors:  Anna Luíza Damaceno Araújo; Gleyson Kleber do Amaral-Silva; Maria Eduarda Pérez-de-Oliveira; Karen Patricia Domínguez Gallagher; Cinthia Veronica Bardalez López de Cáceres; Ana Luiza Oliveira Corrêa Roza; Amanda Almeida Leite; Bruno Augusto Linhares Almeida Mariz; Carla Isabelly Rodrigues-Fernandes; Felipe Paiva Fonseca; Marcio Ajudarte Lopes; Paul M Speight; Syed Ali Khurram; Jacks Jorge Júnior; Manoela Domingues Martins; Oslei Paes de Almeida; Alan Roger Santos-Silva; Pablo Agustin Vargas
Journal:  Virchows Arch       Date:  2021-03-13       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.